Your search found 16 records, sorted by year and then date of acquisition.

1. Baseline Characteristics by Randomization Status in NIDA-CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT). doc type
  May, Jeanine ; Salazar, Dagmar ; Novo, Patricia ; Shmueli-Blumberg, Dikla ; King, Jacquie ; Matthews, Abigail G. ; Rotrosen, John
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Montreal, Canada, June 17-22, 2017.
2. Comparative Effectiveness of Extended-Release Naltrexone versus Buprenorphine-Naloxone for Opioid Relapse Prevention (X:BOT): A Multicenter, Open-Label, Randomized Controlled Trial. doc type
  Novo, Patricia ; Lee, Joshua D. ; Nunes, Edward V. ; Bachrach, Ken ; Bailey, Genie L. ; Bhatt, Snehal ; Farkas, Sarah ; Fishman, Marc J. ; Gauthier, Phoebe ; Hodgkins, Candace C. ; King, Jacquie ;